L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease

Cell therapy is a promising treatment for Parkinson’s disease (PD), however clinical trials to date have shown relatively low survival and significant patient-to-patient variability. Glucagon Like Peptide-1 receptor (GLP-1R) agonists have potential neuroprotective effects on endogenous dopaminergic...

Descripción completa

Detalles Bibliográficos
Autores principales: Elabi, Osama F., Davies, Jeffrey S., Lane, Emma L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618072/
https://www.ncbi.nlm.nih.gov/pubmed/34830228
http://dx.doi.org/10.3390/ijms222212346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618072/
https://www.ncbi.nlm.nih.gov/pubmed/34830228
http://dx.doi.org/10.3390/ijms222212346

Ejemplares similares